Add
Compare:
Overview:
There are 14 differences and 3 similarities between Carbamazepine, Memantine
| Basic Medical Informatin |
| brand name |
| Tegretol |
Namenda, Namenda Xr |
| Treatment For |
| Seizures And Nerve Pain Such As Trigeminal Neuralgia And Diabetic Neuropathy |
Moderate To Severe Dementia Of The Alzheimer's Type |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| D (us) |
B (us) |
| Possible Side Effects |
| Dizziness, Drowsiness, Unsteadiness, Nausea And Vomiting |
|
| Precautions & Contraindications |
| Increased Eye Pressure, Psychosis, Heart, Kidney, Thyroid Or Liver Diseases, Mood Or Mental Problems, Suicidal Thoughts, Seizures, Pregnancy And Breastfeeding |
Epilepsy Or Other Seizure Disorder; Cataracts; Liver Disease; Kidney Disease; Bladder Or Kidney Infection |
| Excretion |
| 2–3% Excreted Unchanged In Urine |
Renal |
| Storage Conditions |
| Room Temperature |
25°c, In An Airtight Container, Keep Away From Children |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet |
Tablet |
| Routes (of administration) |
| Oral |
Oral |
|
Dosage |
| 200 mg |
5 mg (5 mg (Namenda), 7 mg (Namenda XR)) |
| Chemical Data |
| Bioavailability |
| 80 % |
100 % |
| Protein binding |
| 76 % |
Hepatic ( |
| Metabolism |
| Hepatic |
|
| Half Life (hours) |
| 25-65 H (after Several Doses 12-17 H) |
60-100 H |
| Formula |
| C15h12n2o |
C12h21n |
| Molecular mass (g/mol) |
| 236.269 G/mol |
179.3 G/mol |